NCT03827876RecruitingPhase 4
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
An Open-Label Study Evaluating Enstilar® (Calcipotriene and Betamethasone Dipropionate) Foam, 0.005%/0.064% QD in Psoriasis Patients Being Treated With Etanercept or Adalimumab
Source: ClinicalTrials.gov · Last updated 4 Feb 2019 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
4 weeks of adjunctive therapy of Enstilar® QD followed by 12 weeks QOD to patients with 2-10% BSA who are receiving etanercept or adalimumab for at least 24 weeks
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 29 Jan 2019
- Start date
- 16 Jan 2019
- Primary completion date
- 15 Sept 2019
- Lead sponsor
- Psoriasis Treatment Center of Central New Jersey
- Diseases
- Psoriasis
- NCT number
- NCT03827876
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 30
- From 16 Jan 2019 to the primary completion date, 15 Sept 2019
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient not receiving etanercept or adalimumab, or receiving etanercept or adalimumab \<24weeks
Other
- ˂2 or \>10% BSA
- PGA \<2
Who the study is looking for
- Male or female adult ≥ 18 years of age;
- Diagnosis of chronic plaque-type
- Patient with 2-10% BSA
- Physician Global Assessment of 2 or greater
- Patient has been treated with etanercept or adalimumab for a minimum of 24 weeks
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Psoriasis Treatment Center of Central New Jersey Coordinator of this site? Confirm its status | East Windsor | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.